COMMUNIQUÉS West-GlobeNewswire

Sierra Donor Services Honors Donor Heroes, Families During Donate Life Month
11/04/2025
SACRAMENTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- During the month of April, Sierra Donor Services and Donate Life California celebrate Donate Life Month, paying tribute to everyone who has said “yes” to giving the [...]
Allegro demonstrates safety profile of osteoarthritis hydrogel in data presentation at World Congress on Osteoporosis
11/04/2025
Allegro’s microparticle hydrogel hydrocelin has the potential to be a first-in-class disease-modifying injectable treatment for osteoarthritis Preclinical study to be presented at WCO conference shows no pyrogenicity [...]
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements
11/04/2025
- The universal oxygen carrier delivery capabilities of BXT-25 can be monitored, broadening its applications to treat hypoxic diseases - Leading drug candidate ProLectin-M targets galectins in viral infections including [...]
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
11/04/2025
ATLANTA, April 11, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related [...]
BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
11/04/2025
CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction and Elevated Markers of Cardiac Stress Dr. Arshed Quyyumi, Professor of [...]
Scilex Holding Company Announces 1-for-35 Reverse Stock Split
11/04/2025
PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th
11/04/2025
DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day , PetMed Express, Inc. (NASDAQ: PETS) —the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 [...]
FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean
11/04/2025
HOUSTON, April 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and [...]
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
11/04/2025
Conduit Pharmaceuticals files next generation cocrystal patent for VTAMA ® (tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just as the drug approaches [...]
Preliminary Results for the Year Ended 31 December 2024
11/04/2025
April 11, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the Year Ended 31 December 2024 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX [...]
Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
11/04/2025
TORONTO, April 11, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive [...]
ImPact Biotech Announces New Data Presentations at AUA 2025 Highlighting Safety and Efficacy of Padeliporfin VTP
11/04/2025
- Company to present updated preliminary results from ENLIGHTED Phase 3 Study in LG UTUC - - Additional podium presentation to provide updates from long-term evaluation of Padeliporfin VTP in intermediate-risk prostate [...]
Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025
11/04/2025
ORANGE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its first quarter 2025 financial results on Thursday, May 1, 2025, after market close. Following the release, [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/04/2025
BRISBANE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting of inducement [...]
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
11/04/2025
SAN DIEGO, April 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report first quarter 2025 financial results on Thursday, May 8, 2025 after the market closes. [...]
Optima Health to acquire Cognate Health Limited
11/04/2025
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market [...]
American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025
11/04/2025
SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer [...]
BON Announces Apple Polyphenol Commercial Order Signed
11/04/2025
XI'AN, China, April 11, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a [...]
Vantage Biosciences Doses First Patient in Phase 2 Clinical Study of Oral VX-01 for Non-Proliferative Diabetic Retinopathy
11/04/2025
LONDON, April 11, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences , a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first patient has been [...]

Pages